Stage Iv Non-small Cell Lung Cancer: Disease Bioinformatics
Lung cancer begins in the lungs and has become the leading cause of cancer deaths in the United States for both men and women--claiming more lives than colon, ovarian, prostate, and breast cancer combined. There are two types of lung cancer: small and non-small based on the appearance of the cancer cells on the microscope. Non-small cell lung cancer accounts for approximately 85% of lung cancers and include squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Risk for being diagnosed with lung cancer includes smoking, second hand smoke, exposure to radon gas, asbestos, and other chemicals, excessive alcohol use, and a family history. Treatments depend on the stage as well as type of lung cancer but include: surgery, chemotherapy, radiation, targeted drug therapy, and clinical trials. Stage IV non-small cell lung cancer occurs when the cancer has spread to the other lung and/or to the lymph nodes and distant organs and sites. This is the most progressed and aggressive stage of non-small cell lung cancer.
Stage Iv Non-small Cell Lung Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iv Non-small Cell Lung Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1316 products for the study of Stage Iv Non-small Cell Lung Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Stage Iv Non-small Cell Lung Cancer is also known as Metastatic Non-oat Cell Carcinoma Of The Lung, Metastatic Non-small Cell Carcinoma Of Lung, Metastatic Non-small Cell Carcinoma Of The Lung, Metastatic Non-small Cell Lung Carcinoma, Metastatic Nonsmall Cell Lung Cancer.